BSR amp; BHPR Guidelines for the Management of adults with ANCA BSR amp;BHPR指引ANCA成人的管理.docxVIP
- 8
- 0
- 约9.96万字
- 约 65页
- 2017-12-07 发布于江西
- 举报
BSR
BSR Guidelines for the Management of adults with ANCA Associated VasculitisChair of the Guideline Working Group: Dr Richard A WattsApril 2013Section 1 Scope and Purpose1.1 Background to VasculitisThe primary systemic vasculitides are heterogeneous, multi-system disorders characterised by inflammation and necrosis of small and medium blood vessels. Their aetiology is unknown. Three distinct clinico-pathological syndromes, often associated with anti-neutrophil cytoplasmic antibodies (ANCA), called ANCA associated vasculitis (AAV), have been identified and collectively comprise the most common subgroup: granulomatosis with polyangiitis (Wegener’s granulomatosis) (GPA), eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) and microscopic polyangiitis (MPA). Other forms of vasculitis (listed in Table 1) are usually ANCA negative and are defined by their clinico-pathological features. There are no validated diagnostic criteria for AAV. The American College of Rheumatology (ACR) devised classification criteria for different vasculitides including GPA and EGPA but not MPA, and the Chapel Hill consensus conference (CHCC) in 1994 recommended definitions for GPA, EGPA and MPA[1-4] .The CHCC definitions were not intended for classification or diagnosis but provide a useful description of disease and include some features that have been used for classification purposes. The CHCC definitions were updated in 2012 to accommodate developments in knowledge about aetiopathogenesis and ANCA [5]. Lanham reviewed EGPA in 1984 and provided a slightly different and mainly clinically orientated set of classification criteria when compared to the ACR for EGPA [6]].Table 1 Classification of the Vasculitides Adopted by the 2011-2012 International Chapel Hill Consensus Conference Nomenclature of the VasculitidesLarge Vessel Vasculitis Takayasu Arteritis Giant Cell Arteritis Medium Vessel Vasculitis Polyarteritis Nodosa Kawasaki Disease Small Vessel Vasculitis ANCA-Associated Vas
您可能关注的文档
- 2003-2012国家司法考试商法真题(私人整理).doc
- 2004—2010高考英语—山东卷:真题及答案(打印版).doc
- 16、母鸡_(学校公开课).ppt
- 2005口腔诊疗器械消毒技术操作规范解析(AAA).ppt
- 2007江苏街舞大赛协办活动【策划方案】.ppt
- 2007版CAD操作教程与常用快捷键(经典自学材料).doc
- 17-牛顿环&劈尖的等厚干涉.ppt
- 2007高考理综化学部分(山东卷word含答案).doc
- 2008 标志设计趋势(英文版).doc
- 2008-08-18佰草集汉方SPA品牌规划书(低精)【策划方案】.ppt
- 腾讯安全沙龙:红队视角下的海外SRC猎场:战略、战术与突破.pdf
- 【icap】ETS的范围扩展:设计和政策挑战.docx
- bcg -美国最高法院关于关税的裁决对你的企业意味着什么 What Does the US Supreme Court Ruling on Tariffs Mean for Your Business.pdf
- 2026届甘肃兰州市高三下学期第一次模拟考试历史试卷(扫描版,含答案).docx
- bcg -零售银行如何让人工智能代理发挥作用 How Retail Banks Can Put AI Agents to Work.pdf
- 住宅项目规范解读(GB 55038-2025) -培训 - 房地产-2025.docx
- 盘扣式脚手架工程量自动计算表 -培训 -房地产-2025.pdf
- 广东省汕头市2024-2025学年高三下学期第一次模拟考试英语学试题(含答案).docx
- 品牌研究+_+2025+CAPSE中国航司品牌榜单.pdf
- 【银河专题】如何看待豆粕内外价差关系.pdf
原创力文档

文档评论(0)